InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Peterson Amy C., Vice-Président Exécutif du Développement. Director active across 1 companies, notably CytomX Therapeutics, Inc.. In total, 4 filings have been recorded. The latest transaction was disclosed on 2 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
040,000 shares0
Common Stock
SEC:0001567619-22-002525·
040,000 shares0
Common Stock
SEC:0001567619-22-002525:0·
€16,5173,320 shares@ €4.97510.0023% mcap100.0% of flow
Common Stock
SEC:0001567619-21-011806·
€16,5173,320 shares@ €4.97510.0023% mcap50.0% of flow
Common Stock
SEC:0001567619-21-011806:0·
4 of 4 declarations
About Peterson Amy C.
Amy C. Peterson is the Executive Vice President of Development at CytomX Therapeutics, Inc. In this role, she oversees the company's strategic development initiatives, aiming to innovate and improve medical treatments. Her expertise is essential for the success of the company's projects.
